Clinical Trial Update: Phase 1 Study of ART5803 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial of ART5803 in healthy participants is active but not recruiting, sponsored by Arialys Therapeutics, with Autoimmune Encephalitis listed as the con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• ART5803

Snippet

Sponsor: Arialys Therapeutics | Conditions: Autoimmune Encephalitis | Phase 1 | Status: ACTIVE_NOT_RECRUITING